In essence, what we've looked at, and what a number of other organizations, including the CMA, have now looked at and agreed with us is we are overpaying drastically in terms of our drug costs. Part of that has to do with where we're located on the planet, but the other part of it has to do with simply not having a large bargaining unit to be able to cut a better deal.
There are ways to do that, if provinces can get together. We do that at the cancer agency where I work. We essentially have pharmacare for all drugs that treat cancer. We negotiate for the whole province for those drugs. We would be much more efficient and we could cut a better deal if we were all negotiating for the entire country.
Similarly, it is a saving of scale. If we can come to the point of being able to negotiate for all of the pharmaceuticals that are necessary to treat a population base of 35 million, we simply would have more power to be able to deliver more for less.